ISA-95 defines the vertical integration layers — from field devices (Level 0) to ERP (Level 4) — that every GMP-compliant pharmaceutical smart factory is built on. This playbook maps the full implementation journey, from architecture decisions and MES/EBR selection through SCADA/DCS integration and batch automation.
The five ISA-95 levels give every pharma system a shared language. Level 3 (MES/MOM) is the critical GMP boundary where batch records, deviations and electronic signatures live — regulators and auditors expect this boundary to be explicitly documented in URS and FDS submissions.
ANSI/ISA-95.00.01-2025 adds a formal IIoT connectivity model, cloud-to-floor integration patterns and a revised equipment hierarchy that aligns with ISA-88 batch recipe design. New URS documents authored after April 2025 should reference the 2025 edition.
Most Southeast Asian pharma sites are brownfield — legacy PLCs, paper batch records, manual deviations. A brownfield assessment scores existing equipment against ISA-95 levels and identifies minimum connectivity investment needed to support an MES layer without full hardware replacement.
Use this ISA-95 Pharma Automation Playbook page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.
For ISA-95 Pharma Automation Playbook, prepare the records, owners, risks and decision criteria linked to isa-95 layer model for pharma, april 2025 update: iiot and cloud connectivity, brownfield pharma implementation path. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.
ISA-95 itself is not mandated by FDA or EU GMP, but its layer model is the de facto framework that regulators and auditors expect in system architecture documentation. Failing to produce ISA-95-aligned URS/FDS documentation during a 21 CFR Part 11 inspection is a frequent observation gap.
For a single building with 2–4 production lines, a complete implementation from URS to validated MES go-live typically takes 12–18 months. Brownfield projects with legacy DCS integration add 3–6 months. A single-line pilot can be completed in 6–9 months.
ISA-95 defines the vertical integration layers (Levels 0–4) and data objects between them. ISA-88 defines the horizontal structure of batch recipes: procedure, operation, phase, and physical equipment model (process cell, unit, equipment module). Both standards operate together in pharma batch manufacturing — ISA-95 governs data flow from SCADA to MES to ERP; S88 governs how batch recipes are structured and executed.